Skip to main content

Published locations for Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLL

User login

  • Reset your password
  • /content/efficacy-postvenetoclax-therapy-may-depend-prior-agent-exposure-cll
  • /fedprac/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent-exposure-cll
  • /hematologynews/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent-exposure
  • /oncologypractice/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent-exposure
  • /fedprac/avaho/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent-exposure-cll
  • /hematology-oncology/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent
  • /b-cell-lymphoma-icymi/article/213974/cll/efficacy-postvenetoclax-therapy-may-depend-prior-agent